# Bone Marrow Transplantation in Treating Patients With Leukemia, Myelodysplasia, or Lymphoblastic Lymphoma

> **NCT00003187** · PHASE2,PHASE3 · COMPLETED · sponsor: **Virginia Commonwealth University** · enrollment: 19 (actual)

## Conditions studied

- Leukemia
- Lymphoma
- Myelodysplastic Syndromes

## Interventions

- **BIOLOGICAL:** filgrastim
- **DRUG:** cyclophosphamide
- **DRUG:** cyclosporine
- **DRUG:** cytarabine
- **DRUG:** methotrexate
- **DRUG:** methylprednisolone
- **PROCEDURE:** allogeneic bone marrow transplantation
- **PROCEDURE:** in vitro-treated bone marrow transplantation
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00003187
- **Lead sponsor:** Virginia Commonwealth University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1995-05
- **Primary completion:** 2005-02
- **Final completion:** 2005-02
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2010-02-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003187

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003187, "Bone Marrow Transplantation in Treating Patients With Leukemia, Myelodysplasia, or Lymphoblastic Lymphoma". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00003187. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*